Global Aptamers Market - Forecasts from 2021 to 2026
|出版商||Knowledge Sourcing Intelligence||商品編碼||1023146|
|出版日期||內容資訊||英文 114 Pages
|全球適體市場-預測 (2021-2026) Global Aptamers Market - Forecasts from 2021 to 2026|
|出版日期: 2021年07月09日||內容資訊: 英文 114 Pages||
2019 年全球適配體市場規模估計為 1,068,800,000 美元，預計在預測期內將快速增長。
適配子是單鏈 DNA 或 RNA，由於它們能夠形成環和螺旋，因此具有形成各種形狀的特性。一切，例如適體的核酸如何折疊以及適體所在基質的狀態，都會影響與靶標的結合。適配體用途廣泛，可與高選擇性和特異性靶標結合，如蛋白質、□和糖。目前，適配體用於各種疾病的診斷和小分子的檢測。
在過去幾年中，大公司對市場產生了巨大影響。加速研發投入預計將對整體市場增長產生積極影響。 Aptamer 是市場上的領先公司，從事適體開發已超過 25 年。該公司已開發出與蛋白質、小分子、組織、細胞等特異性結合的高親和力適體。該公司還為治療學、生物技術和診斷應用創造了尖端、先進的元素。預計這些趨勢和發展將對預測期內的市場產生積極影響。
The global aptamers market is estimated to be valued at US$1,068.804 million in 2019 and is projected to grow rapidly during the forecast period. Aptamers are single-stranded DNA or RNA and have the property to assume a variety of shapes due to their ability to form loops and helices. The way aptamers fold, the order of the nucleic acids, and the conditions of the matrix they are in, all contribute to binding a target. Owing to their extreme versatility they bind to the target that is highly selective and specific including proteins, peptides, and carbohydrates. Aptamers are currently being used for the diagnosis of various diseases and the detection of small molecules.
Aptamers may be used as pharmaceutical lead selection reagents and functional proteomic levels. The growth in the market may be attributed to the advantages of the aptamer over antibodies such as low cost and high efficiency, coupled with the diverse range of applications offered by the aptamers. Continuous advancement in technologies along with its quick implementation is expected to boost the market growth during the given period. However, a lack of skilled professionals may hamper the market growth during the given period. Major companies have been making a significant impact in the market, in the past few years. The acceleration in the investments in Research and Development is expected to make a positive impact on the overall market growth. Aptagen, a key player in the market, has been involved in aptamer development, over 25 years. The company has been generating specifically binding and high-affinity aptamers, for proteins, small molecules, tissues, and cells. The company has also been producing state of art and advanced elements for therapeutics, bio-industrial and diagnostic applications. These trends and developments are expected to have a positive impact on the market, during the forecast period.
Rising R&D investments in biotechnology and pharmaceutical industries.
The market is expected to surge in the coming years, due to the growth in R&D investments in the pharmaceutical and biotechnology industries. The research-based pharmaceutical and biotechnology industry plays a significant role in the enhancement of a specific region, advancing competitive index, and is essential to the growth of the global economy. According to the European Federation of Pharmaceutical Industries and Associations, the total R&D expenditure in the pharmaceutical sector in Europe had been over EUR35 billion, in the year 2019. India is also expected to play a major role in the overall market growth. The country has been among the top 12 destinations for biotechnology, globally, and has around a 3% share in the biotechnology industry, according to the data given by the National Investment Promotion & Facilitation Agency. Other countries, such as China and the United States are also expected to have a major role in the overall market growth. The United States has been a major destination for research and development. In 2004, the first and novel aptamer therapeutic product, which has been called Macugen was approved by the United States of Food and Drugs Administration. China has become one of the biggest healthcare markets, globally. According to the country's government, the pharmaceutical market had been worth more than US$100 billion in the year 2019. The country has also introduced several reforms to attract biotech investors. These trends are expected to have a positive impact on the market, in the coming years.